Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Inclusion Criteria: * Male and Female subjects requiring non-emergent retroperitoneal or intra-abdominal surgical procedures * Presence of an appropriate soft-tissue target bleeding site (challenging bleeding site for which topical hemostatic adjuncts might typically be used) as identified intra-operatively by the surgeon * Subjects must be willing to participate in the study and provide written informed consent Exclusion Criteria: * Subjects undergoing emergency surgery * Parenchymal or anastomotic bleeding sites will not be considered for randomization * Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure * Subjects with known intolerance to blood products or to one for the components of the study product * Subjects unwilling to receive blood products * Subjects with known autoimmune immunodeficiency diseases (including known HIV * Subjects who are known, current alcohol and/or drug abusers * Subjects who have participated in another investigational drug or device research study within 30 days of enrollment * Female subjects who are pregnant or nursing